Skip to main content
. 2024 Aug 31;30(2):104–119. doi: 10.6118/jmm.23015

Fig. 2. Body weight, height and ovary weight changes in the control and premature ovarian failure groups. Data presented as mean ± standard deviation. aStatistically significant difference from the control group. bStatistically significant difference from the AP39 group. cStatistically significant difference from the Cisplatin group. dStatistically significant difference from the Cisplatin + AP39 group. CIS: chronic immobilization stress.

Fig. 2